The Selective Inhibitor of HDAC6 induces Apoptosis and Synergizes with BTK inhibitor Ibrutinib in follicular lymphoma

2018

Temozolomide-resistant glioblastoma depends on HDAC6 activity through regulating MMR

2018

HDAC6-selective inhibitor has effective and potent anticancer activity in ARID1A-mutated ovarian cancers

2018

The HDAC6-selective inhibitor overcomes the bortezomib resistance in multiple myeloma

2018

A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells

2018